121 related articles for article (PubMed ID: 2241094)
1. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
[TBL] [Abstract][Full Text] [Related]
4. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
6. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
9. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
[TBL] [Abstract][Full Text] [Related]
10. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
12. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
13. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis.
Agnantis NJ; Mahera H; Maounis N; Spandidos DA
Eur J Gynaecol Oncol; 1992; 13(4):309-15. PubMed ID: 1325346
[TBL] [Abstract][Full Text] [Related]
16. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
17. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224
[TBL] [Abstract][Full Text] [Related]
18. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars].
Hu Z; Lou L; Luo S
Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 May; 18(3):165-7. PubMed ID: 12189705
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints.
Agnantis NJ; Apostolikas NA; Zolotas VG; Spandidos DA
Acta Cytol; 1994; 38(3):335-40. PubMed ID: 8191822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
